Cargando…
The influence of cardiac output on propofol and fentanyl pharmacokinetics and pharmacodynamics in patients undergoing abdominal aortic surgery
Cardiac output (CO) is expected to affect elimination and distribution of highly extracted and perfusion rate-limited drugs. This work was undertaken to quantify the effect of CO measured by the pulse pressure method on pharmacokinetics and pharmacodynamics of propofol and fentanyl administrated dur...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7652808/ https://www.ncbi.nlm.nih.gov/pubmed/32840723 http://dx.doi.org/10.1007/s10928-020-09712-1 |
_version_ | 1783607769294700544 |
---|---|
author | Bienert, Agnieszka Sobczyński, Paweł Młodawska, Katarzyna Hartmann-Sobczyńska, Roma Grześkowiak, Edmund Wiczling, Paweł |
author_facet | Bienert, Agnieszka Sobczyński, Paweł Młodawska, Katarzyna Hartmann-Sobczyńska, Roma Grześkowiak, Edmund Wiczling, Paweł |
author_sort | Bienert, Agnieszka |
collection | PubMed |
description | Cardiac output (CO) is expected to affect elimination and distribution of highly extracted and perfusion rate-limited drugs. This work was undertaken to quantify the effect of CO measured by the pulse pressure method on pharmacokinetics and pharmacodynamics of propofol and fentanyl administrated during total intravenous anesthesia (TIVA). The data were obtained from 22 ASA III patients undergoing abdominal aortic surgery. Propofol was administered via target-controlled infusion system (Diprifusor) and fentanyl was administered at a dose of 2–3 µg/kg each time analgesia appeared to be inadequate. Hemodynamic measurements as well as bispectral index were monitored and recorded throughout the surgery. Data analysis was performed by using a non-linear mixed-effect population modeling (NONMEM 7.4 software). Three compartment models that incorporated blood flows as parameters were used to describe propofol and fentanyl pharmacokinetics. The delay of the anesthetic effect, with respect to plasma concentrations, was described using a biophase (effect) compartment. The bispectral index was linked to the propofol and fentanyl effect site concentrations through a synergistic E(max) model. An empirical linear model was used to describe CO changes observed during the surgery. Cardiac output was identified as an important predictor of propofol and fentanyl pharmacokinetics. Consequently, it affected the depth of anesthesia and the recovery time after propofol-fentanyl TIVA infusion cessation. The model predicted (not observed) CO values correlated best with measured responses. Patients‘ age was identified as a covariate affecting the rate of CO changes during the anesthesia leading to age-related difference in individual patient’s responses to both drugs. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s10928-020-09712-1) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-7652808 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-76528082020-11-12 The influence of cardiac output on propofol and fentanyl pharmacokinetics and pharmacodynamics in patients undergoing abdominal aortic surgery Bienert, Agnieszka Sobczyński, Paweł Młodawska, Katarzyna Hartmann-Sobczyńska, Roma Grześkowiak, Edmund Wiczling, Paweł J Pharmacokinet Pharmacodyn Original Paper Cardiac output (CO) is expected to affect elimination and distribution of highly extracted and perfusion rate-limited drugs. This work was undertaken to quantify the effect of CO measured by the pulse pressure method on pharmacokinetics and pharmacodynamics of propofol and fentanyl administrated during total intravenous anesthesia (TIVA). The data were obtained from 22 ASA III patients undergoing abdominal aortic surgery. Propofol was administered via target-controlled infusion system (Diprifusor) and fentanyl was administered at a dose of 2–3 µg/kg each time analgesia appeared to be inadequate. Hemodynamic measurements as well as bispectral index were monitored and recorded throughout the surgery. Data analysis was performed by using a non-linear mixed-effect population modeling (NONMEM 7.4 software). Three compartment models that incorporated blood flows as parameters were used to describe propofol and fentanyl pharmacokinetics. The delay of the anesthetic effect, with respect to plasma concentrations, was described using a biophase (effect) compartment. The bispectral index was linked to the propofol and fentanyl effect site concentrations through a synergistic E(max) model. An empirical linear model was used to describe CO changes observed during the surgery. Cardiac output was identified as an important predictor of propofol and fentanyl pharmacokinetics. Consequently, it affected the depth of anesthesia and the recovery time after propofol-fentanyl TIVA infusion cessation. The model predicted (not observed) CO values correlated best with measured responses. Patients‘ age was identified as a covariate affecting the rate of CO changes during the anesthesia leading to age-related difference in individual patient’s responses to both drugs. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s10928-020-09712-1) contains supplementary material, which is available to authorized users. Springer US 2020-08-25 2020 /pmc/articles/PMC7652808/ /pubmed/32840723 http://dx.doi.org/10.1007/s10928-020-09712-1 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Original Paper Bienert, Agnieszka Sobczyński, Paweł Młodawska, Katarzyna Hartmann-Sobczyńska, Roma Grześkowiak, Edmund Wiczling, Paweł The influence of cardiac output on propofol and fentanyl pharmacokinetics and pharmacodynamics in patients undergoing abdominal aortic surgery |
title | The influence of cardiac output on propofol and fentanyl pharmacokinetics and pharmacodynamics in patients undergoing abdominal aortic surgery |
title_full | The influence of cardiac output on propofol and fentanyl pharmacokinetics and pharmacodynamics in patients undergoing abdominal aortic surgery |
title_fullStr | The influence of cardiac output on propofol and fentanyl pharmacokinetics and pharmacodynamics in patients undergoing abdominal aortic surgery |
title_full_unstemmed | The influence of cardiac output on propofol and fentanyl pharmacokinetics and pharmacodynamics in patients undergoing abdominal aortic surgery |
title_short | The influence of cardiac output on propofol and fentanyl pharmacokinetics and pharmacodynamics in patients undergoing abdominal aortic surgery |
title_sort | influence of cardiac output on propofol and fentanyl pharmacokinetics and pharmacodynamics in patients undergoing abdominal aortic surgery |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7652808/ https://www.ncbi.nlm.nih.gov/pubmed/32840723 http://dx.doi.org/10.1007/s10928-020-09712-1 |
work_keys_str_mv | AT bienertagnieszka theinfluenceofcardiacoutputonpropofolandfentanylpharmacokineticsandpharmacodynamicsinpatientsundergoingabdominalaorticsurgery AT sobczynskipaweł theinfluenceofcardiacoutputonpropofolandfentanylpharmacokineticsandpharmacodynamicsinpatientsundergoingabdominalaorticsurgery AT młodawskakatarzyna theinfluenceofcardiacoutputonpropofolandfentanylpharmacokineticsandpharmacodynamicsinpatientsundergoingabdominalaorticsurgery AT hartmannsobczynskaroma theinfluenceofcardiacoutputonpropofolandfentanylpharmacokineticsandpharmacodynamicsinpatientsundergoingabdominalaorticsurgery AT grzeskowiakedmund theinfluenceofcardiacoutputonpropofolandfentanylpharmacokineticsandpharmacodynamicsinpatientsundergoingabdominalaorticsurgery AT wiczlingpaweł theinfluenceofcardiacoutputonpropofolandfentanylpharmacokineticsandpharmacodynamicsinpatientsundergoingabdominalaorticsurgery AT bienertagnieszka influenceofcardiacoutputonpropofolandfentanylpharmacokineticsandpharmacodynamicsinpatientsundergoingabdominalaorticsurgery AT sobczynskipaweł influenceofcardiacoutputonpropofolandfentanylpharmacokineticsandpharmacodynamicsinpatientsundergoingabdominalaorticsurgery AT młodawskakatarzyna influenceofcardiacoutputonpropofolandfentanylpharmacokineticsandpharmacodynamicsinpatientsundergoingabdominalaorticsurgery AT hartmannsobczynskaroma influenceofcardiacoutputonpropofolandfentanylpharmacokineticsandpharmacodynamicsinpatientsundergoingabdominalaorticsurgery AT grzeskowiakedmund influenceofcardiacoutputonpropofolandfentanylpharmacokineticsandpharmacodynamicsinpatientsundergoingabdominalaorticsurgery AT wiczlingpaweł influenceofcardiacoutputonpropofolandfentanylpharmacokineticsandpharmacodynamicsinpatientsundergoingabdominalaorticsurgery |